Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Omega-3 Supplementation Effects on Polycystic Ovary Syndrome Symptoms and Metabolic Syndrome Publisher



Khani B1, 2 ; Mardanian F1, 2 ; Fesharaki SJ1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2017


Abstract

Background: Polycystic ovary syndrome (PCOS) is the most common female endocrine disorder with unknown etiology and with different complications. The aim of this study was to evaluate the effect of omega-3 supplementation on PCOS symptoms and metabolic syndrome. Materials and Methods: This double-blind clinical trial was performed in 2015 in Alzahra and Shahid Beheshti Hospitals, Isfahan, Iran, on 88 patients with PCOS. Intervention group took omega-3 supplements with dose of 2 g/day for 6 months (two capsules), but control group received two olive oil capsules. Finally, ultrasound and laboratory findings and the recovery rate of menstrual disorders in both groups were compared. Results: After 6 months’ intervention, waist circumference (WC) was significantly lower in omega-3 as compared to control (81.18 ± 2.87 vs. 84.22 ± 2.61 cm, respectively, P < 0.0001). High-density lipoprotein was increased (47.2 ± 1.37 vs. 41.56 ± 1.34 mg/dl, respectively, P < 0.0001) while low-density lipoprotein (107.79 ± 1.68 vs. 117.4 ± 1.57 mg/dl, respectively), triglyceride (116.02 ± 3.13 vs. 125.06 ± 2.91 mg/dl, respectively), and cholesterol (180.34 ± 6.34 vs. 189.56 ± 5.93 mg/dl, respectively) in omega-3 were significantly lower than control (P < 0.0001). The interval between periods in omega-3 was significantly shorter than control (29.83 ± 4.68 vs. 47.11 ± 8.72 days, respectively, P < 0.001). Conclusion: Omega-3 decrease lipid profiles, WC, and interval between periods while weight, hip circumference, fasting blood sugar, number of ovarian follicle, size of ovary, bleeding volume, menstrual bleeding, and hirsutism score did not change by administration of omega-3. © 2017 Journal of Research in Medical Sciences.
Related Docs
View other Related Docs
1. The Effect of N-3 Polyunsaturated Fatty Acid Supplementation on Androgen Status in Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials, Hormone and Metabolic Research (2016)
2. Omega-3 and Vitamin E Co-Supplementation Can Improve Antioxidant Markers in Obese/Overweight Women With Polycystic Ovary Syndrome, International Journal for Vitamin and Nutrition Research (2020)
3. The Effects of Canola and Olive Oils Consumption Compared to Sunflower Oil, on Lipid Profile and Hepatic Steatosis in Women With Polycystic Ovarian Syndrome: A Randomized Controlled Trial, Lipids in Health and Disease (2021)
4. A Meta-Analysis of Effects of Vitamin E Supplementation Alone and in Combination With Omega-3 or Magnesium on Polycystic Ovary Syndrome, Scientific Reports (2022)
5. Cardiometabolic Risk Factors in Polycystic Ovary Syndrome, Pakistan Journal of Medical Sciences (2012)
6. Association Between Major Dietary Patterns and Polycystic Ovary Syndrome: Evidence From a Case-Control Study, Applied Physiology, Nutrition and Metabolism (2019)
7. Effects of Probiotic Supplementation on Hormonal and Clinical Outcomes of Women Diagnosed With Polycystic Ovary Syndrome: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial, Journal of Functional Foods (2022)
8. Effects of Inulin-Type Fructans With Different Degrees of Polymerization on Inflammation, Oxidative Stress and Endothelial Dysfunction in Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial, Clinical Endocrinology (2022)
Experts (# of related papers)
View all Related Experts
Hatav GhasemiTehrani (12)
Ferdous Mehrabian (11)
Other Related Docs
9. The Effect of Synbiotics Supplementation on Anthropometric Indicators and Lipid Profiles in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial, Lipids in Health and Disease (2020)
10. Association Between the Food Security Status and Dietary Patterns With Polycystic Ovary Syndrome (Pcos) in Overweight and Obese Iranian Women: A Case-Control Study, Journal of Ovarian Research (2021)
11. Prevalence of Polycystic Ovary Syndrome in Reproductive-Aged Women With Type 2 Diabetes, Gynecological Endocrinology (2008)
12. Metformin-Therapy Effects in 50 Clomiphene Citrate Resistant Pcos Patients, Journal of Medical Sciences (2006)
13. The Relationship Between Intake of Dairy Products and Polycystic Ovary Syndrome in Women Who Referred to Isfahan University of Medical Science Clinics in 2013, International Journal of Preventive Medicine (2014)
14. Global Prevalence of Polycystic Ovary Syndrome in Women Worldwide: A Comprehensive Systematic Review and Meta-Analysis, Archives of Gynecology and Obstetrics (2024)
15. The Association Between Anthropometric Parameters and Cardiovascular Risk Indicators in Women With Polycystic Ovarian Syndrome, ARYA Atherosclerosis (2020)
16. The Association Between Dietary Antioxidants, Oxidative Stress Markers, Abdominal Obesity and Poly-Cystic Ovary Syndrome: A Case Control Study, Journal of Obstetrics and Gynaecology (2020)
17. Diagnostic Value of Prostate-Specific Antigen in Women With Polycystic Ovary Syndrome, Journal of Research in Medical Sciences (2011)
18. The Effect of Concentrated Pomegranate Juice on Biomarkers of Inflammation, Oxidative Stress, and Sex Hormones in Overweight and Obese Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial, Phytotherapy Research (2023)
19. Calcium Plus Vitamin D Supplementation Influences Biomarkers of Inflammation and Oxidative Stress in Overweight and Vitamin D-Deficient Women With Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial, Clinical Endocrinology (2015)
20. Comparison of the Effects of Metformin, Flutamide Plus Oral Contraceptives, and Simvastatin on the Metabolic Consequences of Polycystic Ovary Syndrome, Journal of Research in Medical Sciences (2016)
21. Effect of Probiotics and Synbiotics on Selected Anthropometric and Biochemical Measures in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis, European Journal of Clinical Nutrition (2020)
22. The Effect of Garlic (Allium Sativum) Supplementation on the Lipid Parameters and Blood Pressure Levels in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial, Phytotherapy Research (2021)
23. The Prevalence of Metabolic Syndrome and Insulin Resistance According to the Phenotypic Subgroups of Polycystic Ovary Syndrome in a Representative Sample of Iranian Females, Journal of Research in Medical Sciences (2011)
24. Inulin-Type Fructans With Different Degrees of Polymerization Improve Insulin Resistance, Metabolic Parameters, and Hormonal Status in Overweight and Obese Women With Polycystic Ovary Syndrome: A Randomized Double-Blind, Placebo-Controlled Clinical Trial, Food Science and Nutrition (2024)
25. Metabolic Response to Folate Supplementation in Overweight Women With Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial, Molecular Nutrition and Food Research (2014)
26. Comparison of the Metabolic Parameters and Androgen Level of Umbilical Cord Blood in Newborns of Mothers With Polycystic Ovary Syndrome and Controls, Journal of Research in Medical Sciences (2012)
27. Evaluation of Changes in Levels of Hyperandrogenism, Hirsutism and Menstrual Regulation After a Period of Aquatic High Intensity Interval Training in Women With Polycystic Ovary Syndrome, International Journal of Preventive Medicine (2019)
28. Comparison of Ovarian Morphology, Pattern of Menstrual Cycles, and Testosterone Level in Polycystic Ovary Syndrome Patients Regarding Body Mass Index Value, Journal of Isfahan Medical School (2009)
29. Prevalence of Polycystic Ovary Syndrome in Girls Aged 14-18 Years in Isfahan, Iran, Hormone Research (2004)
30. The Effects of Curcumin Supplementation on Glycemic Status, Lipid Profile and Hs-Crp Levels in Overweight/Obese Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Complementary Therapies in Medicine (2019)
31. Comparison of the Impact of Intermittent Fasting Diet Alone or in Conjunction With Probiotic Supplementation Versus Calorie-Restricted Diet on Inflammatory, Oxidative Stress, and Antioxidant Capacity Biomarkers in Women With Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Trial, Journal of Research in Medical Sciences (2025)
32. Effects of Omega-3 Fatty Acid Supplementation on Insulin Metabolism and Lipid Profiles in Gestational Diabetes: Randomized, Double-Blind, Placebo-Controlled Trial, Clinical Nutrition (2015)
33. Blood Circulating Levels of Adipokines in Polycystic Ovary Syndrome Patients: A Systematic Review and Meta-Analysis, Reproductive Sciences (2021)
34. The Therapeutic Effects and Mechanisms of Action of Resveratrol on Polycystic Ovary Syndrome: A Comprehensive Systematic Review of Clinical, Animal and in Vitro Studies, Clinical and Experimental Pharmacology and Physiology (2022)
35. Serum Prostate-Specific Antigen Level in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis, Hormone and Metabolic Research (2019)
36. Evaluation of Serum Prolactin Levels in Patients With Polycystic Ovary Syndrome, Journal of Isfahan Medical School (2012)
37. The Effects of Propolis Supplementation on High-Sensitivity C-Reactive Protein, Testosterone Hormone, and Metabolic Profile in Women With Polycystic Ovary Syndrome: A Randomized, Triple-Blinded, Placebo-Controlled Clinical Trial, Phytotherapy Research (2023)
38. Effects of Probiotic Supplementation on Pancreatic Β‑Cell Function and C‑Reactive Protein in Women With Polycystic Ovary Syndrome: A Randomized Double‑Blind Placebo‑Controlled Clinical Trial, International Journal of Preventive Medicine (2015)
39. Effects of Probiotic Supplementation on Pancreatic Β‑Cell Function and C‑Reactive Protein in Women With Polycystic Ovary Syndrome: A Randomized Double‑Blind Placebo‑Controlled Clinical Trial, International Journal of Preventive Medicine (2015)
40. Circulating Resistin and Follistatin Levels in Obese and Non-Obese Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis, PLoS ONE (2021)
41. The Prevalence of Polycystic Ovary Syndrome (Pcos) in Type 2 Diabetic Women in Reprodutive Ages, Iranian Journal of Diabetes and Lipid Disorders (2006)
42. Chromium Supplementation and Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis, Journal of Trace Elements in Medicine and Biology (2017)
43. The Effect of Concentrated Pomegranate Juice Consumption on Risk Factors of Cardiovascular Diseases in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial, Phytotherapy Research (2021)
44. The Effects of Chromium Supplementation on Endocrine Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial, Biological Trace Element Research (2016)
45. Clinical and Metabolic Responses to Magnesium Supplementation in Women With Polycystic Ovary Syndrome, Biological Trace Element Research (2020)
46. Does Carotid Intima-Media Thickness Have Relationship With Polycystic Ovary Syndrome?, International Journal of Preventive Medicine (2013)
47. Comparison of Vitamin D Deficiency in Women With Polycystic Ovary Syndrome Who Referred to Infertility Clinic With Control Group, Journal of Isfahan Medical School (2016)
48. Effect of Soy Phytoestrogen on Metabolic and Hormonal Disturbance of Women With Polycystic Ovary Syndrome, Journal of Research in Medical Sciences (2011)
49. Health System-Related Needs for Healthy Nutritional Behaviors in Adolescent Girls With Polycystic Ovary Syndrome (Pcos): A Qualitative Study in Iran, BMC Health Services Research (2022)
50. The Diagnostic Value of Anti-Mullerian Hormone Marker in Predicting Response to Treatment of Infertility in Patients With Polycystic Ovary Syndrome, Journal of Isfahan Medical School (2016)